Objective: Evaluate whether smoking exposure and depressive symptoms accumulated over 25 years are synergistically associated with subclinical heart disease, measured by coronary artery calcification (CAC). Method: Participants (baseline: 54.5% women; 51.5% Black; age range ϭ 18 -30 years) were followed prospectively from 1985 to 2010 in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Smoking status was queried yearly from Year 0 to Year 25 to compute packyears of smoking exposure. Depressive symptoms were measured on the Center for Epidemiologic Studies Depression (CES-D) scale every 5 years to compute cumulative scores from Year 5 to Year 25. A three-level multinomial logistic regression was used to evaluate the association between cumulative smoking, cumulative depressive symptoms, and their interaction with moderate-risk CAC (score 1-99) and higher-risk CAC (score Ն100) compared with no CAC (score ϭ 0) at Year 25. Models were adjusted for sociodemographic, clinical, and behavioral covariates. Results: Among 3,189 adults, the cumulative Smoking ϫ Depressive Symptoms interaction was not significant for moderate-risk CAC (p ϭ .057), but was significant for higher-risk CAC (p ϭ .001). For adults with a 30-packyear smoking history, average CES-D scores 2, 10, and 16 were, respectively, associated with odds ratios (95% confidence intervals) 3. 40 (2.36 -4.90), 4.82 (3.03-7.66), and 6.25 (3.31-11.83) for higher-risk CAC (all ps Ͻ .05). Conclusion: Cumulative smoking exposure and cumulative depressive symptoms have a synergistic association
with subclinical heart disease, where higher lifetime smoking exposure and depressive symptoms are associated with greater odds of CAC.
Keywords: smoking, depression, coronary artery calcification, atherosclerosis, multiple risk factors Supplemental materials: http://dx.doi.org/10.1037/hea0000425.supp Heart disease is the leading cause of death in the United States and worldwide (Centers for Disease Control and Prevention, 2011; WHO, 2013) , and many modifiable lifestyle factors, such as smoking, physical activity, diet, and obesity, are causally linked to heart disease. More recently, psychological conditions, most notably depression, have been shown to predict worse outcomes among individuals with heart disease (Lichtman et al., 2014) , and there is growing evidence that depression also predicts incident heart disease (Nicholson, Kuper, & Hemingway, 2006; O'Neil et al., 2016) . These factors have primarily been addressed in isolation in the prevention and treatment of heart disease, even though these conditions commonly co-occur and may interactively increase risk for heart disease.
For instance, smoking and depression are both risk factors for heart disease (Baune et al., 2012 ; United States Department of Health & Human Services [USDHHS] , 2014), the two conditions are highly comorbid (Pratt & Brody, 2010) , and the presence of one interferes with treatment of the other (Dodd et al., 2010; Hitsman et al., 2013; Jamal, Willem Van der Does, Cuijpers, & Penninx, 2012) . In a study of over 8,000 male twins, a shared genetic basis for daily smoking, nicotine dependence, and depression was observed, with stronger correlations between monozygotic compared with dizygotic twins (Lyons et al., 2008) . There is further evidence that cigarette smoking predicts depression and greater severity of depressive symptoms (Boden, Fergusson, & Horwood, 2010) , as well as that depression predicts initiation of and progression to daily smoking (Munafò, Hitsman, Rende, Metcalfe, & Niaura, 2008) .
Understanding the potential synergistic association between smoking and depression with heart disease could be improved by examining the underlying factors that indicate risk for future heart disease or cardiac events. Coronary artery calcification (CAC) is a measure of subclinical atherosclerosis and is the best known predictor of future heart disease in asymptomatic individuals (Greenland et al., 2007; Shaw, Raggi, Schisterman, Berman, & Callister, 2003) . Smoking has a dose-dependent association with CAC (Rasmussen et al., 2013) , and smokers with elevated CAC are more likely to suffer cardiac death compared with their nonsmoking counterparts with equal levels of CAC (Shaw, Raggi, Callister, & Berman, 2006) .
Persistent depression is associated with subclinical heart disease, even after adjusting for smoking status (Agatisa et al., 2005; Hamer, Kivimaki, Lahiri, Marmot, & Steptoe, 2010; Janssen et al., 2016; Matthews, Chang, Sutton-Tyrrell, Edmundowicz, & Bromberger, 2010) , and relative risk of CAC progression increases for each incremental increase in depressive symptoms (Janssen et al., 2011) , though the latter study did not adjust for smoking status. In a prior study using data from the Coronary Artery Risk Development in Young Adults (CARDIA) study, Stewart et al. (2012) observed that higher depressive symptoms were associated with greater odds of 5-year incidence of CAC. While these studies have controlled for smoking status, no studies have evaluated the interaction between smoking and depression in relation to subclinical measures of heart disease.
The purpose of the present study was to evaluate whether smoking exposure and depressive symptoms accumulated over 25 years were associated with greater odds of CAC. We hypothesized that these two risk factors would synergistically interact, such that higher levels of cumulative smoking exposure and cumulative depressive symptoms would be associated with greater odds of CAC beyond the independent associations of smoking and depressive symptoms.
Method Study Design and Participants
The Coronary Artery Risk Development in Young Adults (CARDIA) study was designed to examine the development and progression of heart disease in Black and White men and women sampled from four sites in the United States: Birmingham, AL; Minneapolis, MN; Chicago, IL; and Oakland, CA. Sampling occurred such that the participants within and across sites comprised nearly equal parts in race (Black or White), gender (man or woman), education (less than/equal to or more than high school education), and age (18 -24 or 25-30 years). The study was approved by the institutional review board at each site and informed signed consent was obtained from all participants. The initial sample (N ϭ 5,115) was recruited in 1985-1986 (Year 0). Participants were then invited to complete follow-up exams at Years 2, 5, 7, 10, 15, 20 and 25 with 91, 86, 81, 79, 74, 72 , and 72% retention, respectively. Data were collected on a variety of measures related to heart health, from self-report questionnaires to physical exams to imaging measures. The timing of exams and measures are presented in supplemental material Table 1 . The analytic design used exposure variables through Year 25, with the outcome being CAC at Year 25.
Measures
Smoking exposure. Cigarette smoking was evaluated during each in-person CARDIA visit and at yearly contacts over the phone between CARDIA visits. At baseline, participants were asked "Altogether, how many years have you smoked cigarettes regularly?" Smoking status at each follow-up contact was measured by the question "Do you smoke at least 5 cigarettes per week, almost every week?" If yes, participants were then asked "How many cigarettes do you smoke per day on the average?" When applicable, at follow-up exams participants were asked, "How many years ago did you stop?" These data were used to estimate cumulative lifetime exposure to cigarettes in terms of This document is copyrighted by the American Psychological Association or one of its allied publishers.
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packyears, where 1 packyear of smoking exposure is equivalent to smoking 1 pack of cigarettes per day for 1 year (Auer et al., 2014; Pletcher et al., 2012) . Depressive symptoms. Depressive symptoms were measured using the 20-item Center for Epidemiologic Studies Depression (CES-D) scale at exam Years 5, 10, 15, 20, and 25. The CES-D asks about the severity of symptoms an individual has experienced over the past two weeks, and each item is scored from 0 (rarely or none of the time) to 3 (most or all of the time), for a total possible score between 0 and 60, where scores Ն16 are indicative of significantly elevated depressive symptoms (Radloff, 1977) . A cumulative score was calculated for depressive symptoms, as described in detail below (Data Analysis).
Coronary artery calcification. CAC imaging occurred at Year 25, when participants were in middle adulthood (42 to 59 years old). Of those who completed the Year 25 exam, 3,189 participants (91.1% of the exam year sample) participated in the CAC screening. CAC scores were calculated using the validated method originally described by Agatston (Agatston et al., 1990) . CAC screening demonstrated acceptable agreement between the two scans and very high agreement for both intra-and interrater reliability (Carr et al., 2005) . CAC outcomes were categorized into none (lowest risk; Agatston score ϭ 0), moderate-risk (Agatston score 1-99), versus higher-risk (Agatston score Ն100) CAC, and also analyzed as continuous scores among individuals with CAC Ͼ0 (described and presented in supplemental material).
Covariates. Year 25 sociodemographic, clinical, and behavioral variables that have been shown to be associated with CAC and heart disease were included in the analysis models as covariates (Allen et al., 2014; Bild et al., 2001; Loria et al., 2007; Reis et al., 2013; Yan et al., 2006) . Sociodemographic variables included gender (male vs. female), race (White vs. Black), age (in years), and education (in years). To adjust for the race by gender effect on heart disease and CAC (i.e., higher prevalence of CAC among White males: Loria et al., 2007) , these variables were included in the model as a single, four-level gender (Male ϫ Female) by race (White ϫ Black) interaction variable, where White women was the reference category. These variables were determined at baseline and confirmed at Year 2 (gender and race) or queried at each subsequent exam (age and education).
Clinical variables were total cholesterol (mg/dL), systolic blood pressure (SBP; mmHg), diastolic blood pressure (DBP; mmHg), body mass index (BMI; kg/m 2 ), and diabetes status. Total cholesterol, SBP, DBP, and BMI were modeled continuously. Diabetes was dichotomized (yes ϭ 1, no ϭ 0), diagnosed by at least one of the following: (a) fasting glucose Ն126 mg/dL, (b) 2-hr oral glucose tolerance test result Ն200 mg/dL, (c) hemoglobin A1c (HbA1c) Ն6.5%, and/or (d) current use of diabetic medications.
Behavioral variables were alcohol use and physical activity, measured at each exam year through Year 25. Alcohol use was measured at each exam by the question, "Did you drink any alcoholic beverages in the past year?" If a participant answered yes, he or she was then queried as to the number of drinks of beer, wine, and hard liquor consumed in a typical week. From these responses, a continuous, cumulative drinkyears variable was calculated by multiplying the average daily alcohol use by the number of years drinking (Pletcher et al., 2005) . A physical activity intensity score was derived from the CARDIA Physical Activity History Questionnaire (Jacobs, Hahn, Haskell, Pirie, & Sidney, 1989) , which queries participants about the time spent performing vigorous and moderate intensity physical activities over the past 12 months.
Data Analysis
All participants who underwent CAC screening at Year 25 were included in the present analyses. Because heart disease risk factors tend to change and accumulate over time, cumulative exposure to the independent variables were measured by estimating areas under the curves (AUCs) using a three-step procedure, as has been done previously (Auer et al., 2016; Yaffe et al., 2014) . AUCs were estimated for depressive symptoms (CES-D scores), total cholesterol, SBP, DBP, BMI, and physical activity. First, the population mean trajectory of each variable was estimated using linear mixed models (further details are provided in the supplemental material). Second, participant-specific trajectories were calculated for each variable by combining the random effects best linear unbiased predictions (BLUPs) with the fixed effect estimates. Finally, AUCs were calculated over the interval from baseline (Year 0) to the outcome exam (Year 25). To simplify the interpretation of the AUCs, each value was divided by 25 to obtain time-weighted averages (TWA) of the AUCs, corresponding to the number of years of observation from the first exam (Year 0) through the final exam (Year 25). For depressive symptoms, the AUCs were divided by 20, as the CES-D was given starting at the Year 5 exam. Further detail is provided in the supplemental material. To compute cumulative exposures for smoking and alcohol use, backward and forward linear imputation was used to interpolate missing data between visits. By using mixed models for computing AUCs, which use maximum likelihood estimations, it was unnecessary to compute missing data between visits for those variables (Vittinghoff, Glidden, Shiboski, & McCulloch, 2012) .
A three-level multinomial logistic regression was run to evaluate CAC 1-99 or CAC Ն100 compared with CAC ϭ 0. First, the smoking and depressive symptoms main effects terms were included, as well as the Gender ϫ Race, education, BMI, total cholesterol, SBP, DBP, diabetes, physical activity, and alcohol use covariates (Model 1). Second, the model was adjusted for the Smoking ϫ Depressive Symptoms interaction (Model 2). Finally, to more fully examine the association between depressive symptoms with CAC among individuals with different levels of smoking exposure, interactions between depressive symptoms and the clinical and behavioral covariates were individually added and removed to assess for changes in the association between the Smoking ϫ Depressive Symptoms interaction with CAC (Model 3). A likelihood ratio test was used to evaluate for significant improvements for each model adjustment.
In sensitivity analyses, we examined the effects of using concurrent, Year 25 measures of smoking (cigarettes per day at Year 25) and depressive symptoms (CES-D at Year 25). First, we further adjusted the primary multinomial logistic regression model for Year 25 smoking, Year 25 depressive symptoms, and their interaction. Second, the three-level multinomial logistic regression analysis was performed using only concurrent exposures, including Year 25 smoking, Year 25 depressive symptoms, their interaction, and Year 25 measures of covariates (i.e., cholesterol, SBP, This document is copyrighted by the American Psychological Association or one of its allied publishers.
DBP, BMI, diabetes status, physical activity score, past 24-hr alcohol use, and the sociodemographic covariates). To test the assumption that measuring cumulative exposures of variables would significantly improve the model predicting CAC, a likelihood ratio test was used to compare the fit of the these models with the fit of the primary, cumulative exposures-only model. Analyses were conducted using STATA 13. A threshold of p Ͻ .05 was used to determine significance.
Results

Description of the Sample
The number of participants who underwent CAC screening at Year 25 was 3,189. Of the total sample, 907 participants (28.4%) had any CAC (Agatston score Ͼ0) at Year 25, where 597 participants had moderate-risk CAC (1-99) and 310 participants had higher-risk CAC (Ն100). Agatston scores ranged from 0 to 5950, with a mean score of 38 (SD ϭ 193). The characteristics of the sample by CAC status are presented in Table 1 . Significant correlations were observed between the cumulative smoking packyears and Year 25 cigarettes per day (r ϭ .73) and between cumulative depressive symptoms and Year 25 CES-D score (r ϭ .77), ps Ͻ .001. For smoking, less than 1.0% of the values were missing across the exam years. For depression, 1.5% of the values were missing across the exam years. Further information about missing data are provided in supplemental material Table 2 .
Cumulative Exposures Smoking ؋ Depressive Symptoms Interaction and CAC at Year 25
The odds ratios (ORs) for smoking are representative of higher odds per 10 packyears of smoking. The ORs for depressive symptoms are representative higher odds per each 16 points in the TWA-AUC CES-D score. In Model 1, smoking was significantly associated with CAC 1-99 (OR: 1.38, 95% confidence interval, CI [1.25-1.53] ) and CAC Ն100 (OR: 1.50, 95% CI [1.33-1.70]), ps Ͻ .05, whereas depressive symptoms were not significantly associated with either level of CAC relative to CAC ϭ 0, ps Ͼ .05. In Model 2, the Smoking ϫ Depressive Symptoms interaction term was significant for CAC 1-99 and CAC Ն100, ps Ͻ .05 (see Table  2 for full model results). The likelihood ratio test did not indicate significant improvement in Model 2 relative to Model 1, p ϭ .057.
For both CAC 1-99 and CAC Ն100, among participants with packyears ϭ 0 we did not observe an association between depressive symptoms and CAC. In contrast, among participants with packyears Ͼ0, higher levels of depressive symptoms accumulated over 25 years were associated with greater odds of CAC. For CAC 1-99 ( 11.1 (7.9) 10.2 (6.9) 13.5 (9.7) 10.9 (7.7) .003 Depressive symptoms CES-D score, median d (IQR) 8.7 (7.6) 8.7 (7.5) 8.6 (7.4) 9.6 (9.5) .085 Year 25 CES-D score, mean (SD) 7.8 (9.5) 9.5 (7.8) 9.3 (7.4) 10.1 (7.9) .394
Note. Values for the following variables are the TWA-AUC estimates: total cholesterol, SBP, DBP, BMI, physical activity score, alcohol use, smoking, and CES-D score. These values are presented as median (IQR). CAC ϭ coronary artery calcification; IQR ϭ interquartile range; SD ϭ standard deviation; SBP ϭ systolic blood pressure; DBP ϭ diastolic blood pressure; BMI ϭ body mass index; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. a Mean drinkyears among ever drinkers, N ϭ 1,751 (CAC ϭ 0: n ϭ 1,217, CAC 1-99: n ϭ 352, CAC Ն 100: n ϭ 182). b Mean packyears among ever smokers, N ϭ 1,576 (CAC ϭ 0: n ϭ 1,059, CAC 1-99: n ϭ 319, CAC Ն 100: n ϭ 201).
c Mean cigarettes/day among Year 25 smokers, N ϭ 568 (CAC ϭ 0: n ϭ 337, CAC 1-99: n ϭ 129, CAC Ն 100: n ϭ 102).
d TWA-AUC CES-D score: N ϭ 3,188 (CAC ϭ 0: n ϭ 2,281, CAC 1-99: n ϭ 597, CAC Ն 100: n ϭ 310). This document is copyrighted by the American Psychological Association or one of its allied publishers.
1-99. For CAC Ն100 (Table 4) 
Cumulative Exposures Smoking ؋ Depressive Symptoms Interaction and CAC at Year 25, With Alcohol Use ؋ Depressive Symptoms Interaction
To examine potential moderating factors that may explain why depression was associated with CAC among participants with packyears Ͼ0, but not among participants with packyears ϭ 0, the interactions between depressive symptoms and the clinical and behavioral covariates were included in the model. Only the Alcohol Use ϫ Depressive Symptoms interaction was found to have a modifying influence on the association between depressive symptoms and CAC (Model 3). The Alcohol Use ϫ Depressive Symptoms interaction was significant for CAC 1-99, p ϭ .048, but not for CAC Ն100, p ϭ .379. The Smoking ϫ Depressive Symptoms interaction was no longer significant for CAC 1-99 (p ϭ .057), but remained significant for CAC Ն100, p ϭ .001 (full model results presented in Table 5 ). Likelihood ratio tests indicated that Model 3 was not a significant improvement relative to Model 2, p ϭ .051, but Model 3 was a significant improvement relative to Model 1, p ϭ .019.
The interaction of Smoking ϫ Depressive Symptoms associated with CAC 1-99 was more evident for smokers (packyears Ͼ0) who did not drink alcohol (drinkyears ϭ 0, Table 6 ) compared with those who consumed moderate levels of alcohol (drinkyears ϭ 8, Table 7 ). In fact, among participants with no smoking history (packyears ϭ 0) and a moderate history of alcohol use For CAC Ն100, the interaction of Smoking ϫ Depressive Symptoms was observed for all participants with packyears Ͼ0, whether they drank alcohol (Table 9) or not (Table 8) . Specifically, the combination of high smoking exposure (30 packyears) and clinically elevated depressive symptoms (TWA-AUC CES-D score of 16) was associated with the highest odds of CAC at 0 drinkyears (OR: 9.10, 95% e To facilitate interpretation of the interaction, please see Table 3 (CAC 1-99) and Table  4 (CAC Ն 100). This document is copyrighted by the American Psychological Association or one of its allied publishers.
Year 25 Smoking ؋ Depressive Symptoms Interaction and CAC at Year 25
When the primary model was adjusted for the Year 25 measures of smoking, depressive symptoms, and the Smoking ϫ Depressive Symptoms interaction, the only significant association between these Year 25 measures and CAC was observed between Year 25 smoking with CAC 1-99 (supplemental material Table 3 ). The cumulative Smoking ϫ Depressive Symptoms interactions remained significant for both CAC 1-99 and CAC Ն100 (relative to CAC ϭ 0; ps Ͻ .05), and there was not a significant improvement in model fit by including these Year 25 measures (R 2 ϭ 15.9 vs. 16.1%), p ϭ .368.
In the three-level multinomial logistic regression model evaluating the association between only Year 25 exposures with CAC 1-99 and CAC Ն100, relative to CAC ϭ 0, the Year 25 Smoking ϫ Depressive Symptoms interaction was not significant for CAC 
Discussion
In a large, diverse sample, we tested the hypothesis that chronic smoking exposure and elevated depressive symptoms over 25 years would have an interactive association with subclinical heart disease. The hypothesized association between higher levels of depressive symptoms with greater odds of both moderate-risk and high-risk CAC was observed among all participants with a history of smoking exposure. In both instances, the association between depressive symptoms and CAC was strongest among adults with greater smoking exposure compared with adults with less smoking exposure. The observed associations among cumulative smoking, depressive symptoms, and CAC were largely independent of other sociodemographic, clinical, and behavioral factors associated with CAC and heart disease.
Among adults with a 10-packyear smoking history, those with minimal depressive symptoms (average CES-D score ϭ 2), compared with those with clinically elevated depressive symptoms (average CES-D score ϭ 16), did not have greater odds of moderate-risk CAC. However, among adults with a 30-packyear smoking history, minimal depressive symptoms versus those with clinically elevated depressive symptoms were associated with 2.60 and 3.91 greater odds of moderate-risk CAC, respectively, relative to adults with no smoking history and no depressive symptoms. For higher-risk CAC, a higher level of accumulated depressive symptoms was associated with CAC at all levels of smoking exposure (packyears Ͼ0). Among individuals with a 10-packyear smoking history, minimal depressive symptoms and clinically elevated depressive symptoms were associated with 1.50 and 1.84 greater odds, respectively, of higher-risk CAC. Among adults with a 30-packyear smoking history, minimal depressive symptoms and clinically elevated depressive symptoms were, respectively, associated with 3.40 and 6.25 greater odds of higher-risk CAC.
When examining whether other health-related behaviors moderated this association, we observed an inverse association between depressive symptoms and moderate-risk CAC among participants without any smoking history and a moderate history of alcohol use. Specifically, the odds of moderate-risk CAC among nonsmokers and moderate drinkers were lower among individuals with elevated depressive symptoms; the association between alco- (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve.
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hol use and moderate-risk CAC was not significant. Given the association between depressive disorders and alcohol use (Brière, Rohde, Seeley, Klein, & Lewinsohn, 2014; Grant & Harford, 1995) , one speculative hypothesis is that depressed adults who do not smoke may be more likely to engage in alcohol use as a coping behavior (Holahan, Moos, Holahan, Cronkite, & Randall, 2003; Young-Wolff, Kendler, Sintov, & Prescott, 2009 ), which appears to have a cardioprotective effect at moderate levels (Mukamal et al., 2003; Poli et al., 2013) . Using cumulative measures of smoking and depressive symptoms, as well as covariates, assessed over 25 years explained significantly more of the variance than using concurrent Year 25 measures alone, improving the relative model fit by 35%. This finding is consistent with previous studies showing that smoking is a dose-dependent predictor of CAC (Loria et al., 2007; Rasmussen et al., 2013) , where higher levels of smoking accumulated over 25 years was associated with greater odds of CAC at Year 25. Perhaps more importantly, this finding supports the hypothesis that CAC development is related to long-term elevated depressive symptoms or chronic major depressive disorder (Agatisa et al., 2005; Hamer et al., 2010; Matthews et al., 2010) , rather than a current symptom profile (Devantier et al., 2013; Diez Roux et al., 2006) . A previous analysis of CARDIA data, however, found an association between depressive symptoms at Year 15 and 5-year incident CAC using the CARDIA study data (Stewart et al., 2012) . Clinically, these findings suggest that gathering a thorough history of smoking (e.g., number of years smoking) and depression (e.g., number and severity of depressive episodes) may improve understanding of the influence of depression on CVD.
The association between smoking and depression is wellestablished (Lyons et al., 2008; Munafò et al., 2008) . Numerous mechanisms have been proposed to explain how smoking (USDHHS, 2010) and depression (Davidson, 2012) separately promote atherosclerosis and, ultimately, heart disease. Several of the proposed biological (e.g., systemic inflammation, endothelial dysfunction, and oxidative stress) and behavioral (e.g., physical inactivity and excessive alcohol use) mechanisms for the association between smoking and heart disease overlap with those relating depression and heart disease (Carney, Freedland, Miller, & Jaffe, 2002; Freedland, Carney, & Skala, 2005) . For example, one proposed hypothesis is that depression causes dysfunction in the anti-inflammatory response (Miller, Cohen, & Ritchey, 2002; Stewart, Rand, Muldoon, & Kamarck, 2009) . Therefore, when an inflammatory response is prompted by smoking (van der Vaart, Postma, Timens, & Ten Hacken, 2004), 10, 15, 20, and 25. e To facilitate interpretation of the interaction, please see Tables 6 through 9 .
depressed adults compared with nondepressed adults may have a greater and/or more prolonged inflammatory response. Over time, this continuously augmented inflammation among depressed adults who smoke could accelerate the progression of atherosclerosis (Ridker, Hennekens, Buring, & Rifai, 2000) . Smoking cessation is associated with decreases in depression, anxiety and stress, and with increases in quality of life and positive affect (Taylor et al., 2014) . Therefore, treatment that targets comorbid smoking and depression to decrease cardiovascular disease and improve cardiovascular health may be a fruitful area for future research.
A strength of this study is the use of longitudinal data to assess the interaction of key heart disease risk factors (i.e., smoking and depressive symptoms) over a 25-year follow-up period rather than a snapshot of concurrent symptoms or retrospective reports. Our study utilized measures of current smoking and depressive symptomatology at multiple exams over 25 or 20 years, respectively, which has been shown to be more accurate than retrospective reporting, particularly with regard to self-evaluation of mood intensity (Schwarz, 2007) . By measuring cumulative smoking and repeatedly evaluating current depressive symptoms, we were able (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. (Radloff, 1977) . CAC ϭ coronary artery calcification; CES-D ϭ Center for Epidemiologic Studies Depression scale; TWA ϭ time-weighted average; AUC ϭ area under the curve. This document is copyrighted by the American Psychological Association or one of its allied publishers.
to model the chronicity of smoking and depressive symptoms over time. With regard to depressive symptoms, our results are similar to those reported by Hamer et al. (2010) and Janssen et al. (2016) in that the authors observed that persistent episodes, but not one episode of elevated depressive symptoms, predicted CAC. In the Hamer et al. study, however, the authors only evaluated cognitive depressive symptoms rather than a more global measure such as that used in the present study, and both studies measured number of episodes with elevated depressive symptomatology rather than using a cumulative measure of depressive symptoms over time.
The sample size and sampling procedures in the CARDIA study permit generalizability of findings to middle-aged adults in the United States. The prevalence of Year 25 smoking in this sample (18%) is consistent 2010 reports of United States smoking prevalence (Garrett, Dube, Trosclair, Caraballo, & Pechacek, 2011) . The prevalence of depression in this sample (40%) is consistent with estimates of lifetime prevalence of self-reported depression (Kruijshaar et al., 2005) , though higher than lifetime prevalence estimates of major depressive disorder diagnosis (Kessler et al., 2003) .
One limitation of our study was that the rate of moderate-risk CAC in this sample was low (28%), and the distribution of scores Ͼ0 was nonnormal. Therefore, our interpretation about the amount of CAC among individuals with any CAC may be limited. However, many other studies, including those conducted with CARDIA data, have dichotomized CAC because these data have a large positive skew. Moreover, presence versus absence of CAC in younger adults, such as those in the CARDIA sample, is more indicative of poor heart disease outcomes compared with older individuals with equal levels of CAC (Kondos et al., 2003) . Second, although using the area under the curve (AUC) analyses for smoking and depressive symptoms allowed us to model the cumulative burden of smoking and depression over time, this approach does not permit us to explore the association with patterns of smoking or depression occurring over the course of the study and CAC. Future studies could explore these aspects (e.g., using latent growth curve analyses).
Future studies should examine potential mechanisms (biological and behavioral) for the smoking by depression interaction in healthy individuals to further understanding about how smoking and depression synergistically increase heart disease risk. In addition, the interaction between smoking and depression should be examined for its association with clinical heart disease (e.g., fatal and nonfatal myocardial infarction or stroke) to further elucidate the degree and specificity of the interactive effect of these two risk conditions on primary heart disease.
Among adults with an extensive smoking history, elevated depressive symptoms appears to be a particularly strong risk factor for subclinical heart disease. This has implications for treatment, where depressed adults who smoke may experience the greatest cardiovascular benefits if these two modifiable risk factors are addressed concurrently. Moreover, accounting for the accumulation of smoking and depression over 25 years improved prediction of Year 25 CAC compared with concurrent measurements of smoking status and depressive symptoms status, underscoring the need to gather a complete history of smoking and depression among patients at risk for heart disease. Understanding how key risk factors interact to influence the onset and progression of heart disease may serve to improve the timing and efficacy of heart disease prevention efforts. Future studies should to continue to examine how smoking, depression, and other behavioral factors interact at the subclinical level of heart disease to more fully elucidate the mechanisms of action for these risk factors on heart health, which has implications for preventing and treating modifiable risk factors for heart disease.
